Literature DB >> 8387313

Disruption of human eyeblink conditioning after central cholinergic blockade with scopolamine.

P R Solomon1, M E Groccia-Ellison, D Flynn, J Mirak, K R Edwards, A Dunehew, M E Stanton.   

Abstract

Human (Homo sapiens) volunteers (N = 72) received saline, a low dose of oral scopolamine (0.6 mg), a high dose of oral scopolamine (1.2 mg), or a peripheral analogue (glycopyrrolate). They then underwent classical conditioning of the eyeblink response to a tone conditioned stimulus (CS) and a corneal airpuff unconditioned stimulus (UCS) in a delay conditioning paradigm. There was a dose-related decline in acquisition of the conditioned response. These drug-induced conditioning deficits were similar to those previously reported in rabbit eyeblink conditioning and could not be attributed to such nonassociative factors as changes in auditory thresholds to the tone CS, magnitude of reflexive blinks to the airpuff UCS, or to changes in spontaneous blink rates.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8387313     DOI: 10.1037//0735-7044.107.2.271

Source DB:  PubMed          Journal:  Behav Neurosci        ISSN: 0735-7044            Impact factor:   1.912


  11 in total

1.  The effects of scopolamine, lorazepam, and glycopyrrolate on classical conditioning of the human eyeblink response.

Authors:  M Bahro; B G Schreurs; T Sunderland; S E Molchan
Journal:  Psychopharmacology (Berl)       Date:  1995-12       Impact factor: 4.530

Review 2.  Neuromodulation by glutamate and acetylcholine can change circuit dynamics by regulating the relative influence of afferent input and excitatory feedback.

Authors:  Lisa M Giocomo; Michael E Hasselmo
Journal:  Mol Neurobiol       Date:  2007-07-20       Impact factor: 5.590

3.  A comparison of latent inhibition and learned irrelevance pre-exposure effects in rabbit and human eyeblink conditioning.

Authors:  M Todd Allen; Lori Chelius; Vivek Masand; Mark A Gluck; Catherine E Myers; Geoffrey Schnirman
Journal:  Integr Physiol Behav Sci       Date:  2002 Jul-Sep

4.  Discrimination reversal conditioning of an eyeblink response is impaired by NMDA receptor blockade.

Authors:  J D Churchill; J T Green; S E Voss; E Manley; J E Steinmetz; P E Garraghty
Journal:  Integr Physiol Behav Sci       Date:  2001 Jan-Mar

5.  Cholinergic effects on fear conditioning I: the degraded contingency effect is disrupted by atropine but reinstated by physostigmine.

Authors:  Sebastien Carnicella; Laure Pain; Philippe Oberling
Journal:  Psychopharmacology (Berl)       Date:  2005-02-05       Impact factor: 4.530

6.  Metrifonate increases neuronal excitability in CA1 pyramidal neurons from both young and aging rabbit hippocampus.

Authors:  M M Oh; J M Power; L T Thompson; P L Moriearty; J F Disterhoft
Journal:  J Neurosci       Date:  1999-03-01       Impact factor: 6.167

7.  Efficacy of Maternal Choline Supplementation During Pregnancy in Mitigating Adverse Effects of Prenatal Alcohol Exposure on Growth and Cognitive Function: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.

Authors:  Sandra W Jacobson; R Colin Carter; Christopher D Molteno; Mark E Stanton; Jane S Herbert; Nadine M Lindinger; Catherine E Lewis; Neil C Dodge; H Eugene Hoyme; Steven H Zeisel; Ernesta M Meintjes; Christopher P Duggan; Joseph L Jacobson
Journal:  Alcohol Clin Exp Res       Date:  2018-06-15       Impact factor: 3.455

Review 8.  Dissociating basal forebrain and medial temporal amnesic syndromes: insights from classical conditioning.

Authors:  Catherine E Myer; Deborah Bryant; John DeLuca; Mark A Gluck
Journal:  Integr Physiol Behav Sci       Date:  2002 Apr-Jun

9.  The effect of scopolamine in older rabbits tested in the 750 ms delay eyeblink classical conditioning procedure.

Authors:  Diana S Woodruff-Pak; John T Green; Jonathan T Pak; Boris Heifets; Michelle H Pak
Journal:  Integr Physiol Behav Sci       Date:  2002 Apr-Jun

Review 10.  Harnessing the power of theta: natural manipulations of cognitive performance during hippocampal theta-contingent eyeblink conditioning.

Authors:  Loren C Hoffmann; Joseph J Cicchese; Stephen D Berry
Journal:  Front Syst Neurosci       Date:  2015-04-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.